Lab tries to make COVID-19 treatment for high-risk patients more accessible

MONROE, N.C. — Monoclonal antibody infusion used to treat COVID-19 in high-risk patients is effective but difficult to administer.

The FDA approved the treatment for emergency use only.

[‘Best-kept secret’: Antibody treatment for COVID-19 that experts say saves lives available in area]

“These proteins are specifically designed to neutralize COVID by binding to the virus and preventing it from entering the human cell,” said Benjamin Karsai, with Monroe Biomedical Research.

[WANT TO WATCH ON OUR STREAMING APPS? CLICK HERE]

In the video at the top of this webpage, anchor Genevieve Curtis reports on a lab in Monroe that is attempting to make the treatment more accessible.